536 related articles for article (PubMed ID: 27106296)
21. Predicting 1-year risk for relapse in patients who have discontinued or continued quetiapine after remission from first-episode psychosis.
Hui CL; Wong GH; Tang JY; Chang WC; Chan SK; Lee EH; Lam MM; Chiu CP; Law CW; Chung DW; Tso S; Pang EP; Chan KT; Wong YC; Mo FY; Chan KP; Hung SF; Honer WG; Chen EY
Schizophr Res; 2013 Oct; 150(1):297-302. PubMed ID: 23993865
[TBL] [Abstract][Full Text] [Related]
22. Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction).
Moncrieff J; Lewis G; Freemantle N; Johnson S; Barnes TRE; Morant N; Pinfold V; Hunter R; Kent LJ; Smith R; Darton K; Horne R; Crellin NE; Cooper RE; Marston L; Priebe S
BMJ Open; 2019 Nov; 9(11):e030912. PubMed ID: 31780589
[TBL] [Abstract][Full Text] [Related]
23. You say "schizophrenia" and I say "psychosis": Just tell me when I can come off this medication.
Zipursky RB; Odejayi G; Agid O; Remington G
Schizophr Res; 2020 Nov; 225():39-46. PubMed ID: 32115315
[TBL] [Abstract][Full Text] [Related]
24. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
25. Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol.
Weller A; Gleeson J; Alvarez-Jimenez M; McGorry P; Nelson B; Allott K; Bendall S; Bartholomeusz C; Koval P; Harrigan S; O'Donoghue B; Fornito A; Pantelis C; Paul Amminger G; Ratheesh A; Polari A; Wood SJ; van der El K; Ellinghaus C; Gates J; O'Connell J; Mueller M; Wunderink L; Killackey E
Early Interv Psychiatry; 2019 Dec; 13(6):1345-1356. PubMed ID: 30488637
[TBL] [Abstract][Full Text] [Related]
26. The relapse rate and predictors of relapse in patients with first-episode psychosis following discontinuation of antipsychotic medication.
Di Capite S; Upthegrove R; Mallikarjun P
Early Interv Psychiatry; 2018 Oct; 12(5):893-899. PubMed ID: 27734591
[TBL] [Abstract][Full Text] [Related]
27. Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication.
Conus P; Cotton SM; Francey SM; O'Donoghue B; Schimmelmann BG; McGorry PD; Lambert M
Schizophr Res; 2017 Jul; 185():130-136. PubMed ID: 28065484
[TBL] [Abstract][Full Text] [Related]
28. Rate of and time to symptomatic remission in first-episode psychosis in Northern Malawi: A STROBE-compliant article.
Kaminga AC; Dai W; Liu A; Myaba J; Banda R; Wen SW; Pan X
Medicine (Baltimore); 2018 Nov; 97(45):e13078. PubMed ID: 30407306
[TBL] [Abstract][Full Text] [Related]
29. Relapse rates following antipsychotic discontinuation in the maintenance phase after first-episode of schizophrenia: Results of a long-term follow-up study.
Üçok A; Kara İA
Schizophr Res; 2020 Nov; 225():31-38. PubMed ID: 31653578
[TBL] [Abstract][Full Text] [Related]
30. Research on maintenance treatment to prevent relapse of psychotic disorders.
Hui CL
Psychiatry Res; 2022 Nov; 317():114928. PubMed ID: 37732867
[TBL] [Abstract][Full Text] [Related]
31. Predictors of hospitalisation and recovery following full antipsychotic discontinuation in first episode psychosis. A naturalistic retrospective cohort study.
Wilson M; Harris M; Pereira M; Buckle J; Forshall E; Murphy T; Thompson A; Kavanagh G; Whale R
Schizophr Res; 2023 Nov; 261():269-274. PubMed ID: 37862826
[TBL] [Abstract][Full Text] [Related]
32. Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis.
Alvarez-Jiménez M; Parker AG; Hetrick SE; McGorry PD; Gleeson JF
Schizophr Bull; 2011 May; 37(3):619-30. PubMed ID: 19900962
[TBL] [Abstract][Full Text] [Related]
33. Protocol of guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis based on pragmatic design.
Liu CC; Hsieh MH; Chien YL; Liu CM; Lin YT; Hwang TJ; Hwu HG
Early Interv Psychiatry; 2022 Feb; 16(2):178-185. PubMed ID: 33751764
[TBL] [Abstract][Full Text] [Related]
34. Guidelines for Discontinuation of Antipsychotics in Patients Who Recover From First-Episode Schizophrenia Spectrum Disorders: Derived From the Aggregated Opinions of Asian Network of Early Psychosis Experts and Literature Review.
Asian Network of Early Psychosis Writing Group
Int J Neuropsychopharmacol; 2022 Sep; 25(9):737-758. PubMed ID: 35451023
[TBL] [Abstract][Full Text] [Related]
35. Predictors of 'all-cause discontinuation' of initial oral antipsychotic medication in first episode psychosis.
Mustafa S; Joober R; Lepage M; Iyer S; Shah J; Malla A
Schizophr Res; 2018 Nov; 201():287-293. PubMed ID: 29706449
[TBL] [Abstract][Full Text] [Related]
36. Psychiatrists' opinion towards medication discontinuation in remitted first-episode psychosis: A multi-site study of the Asian Network for Early Psychosis.
Hui CL; Wong AK; Leung WW; Lee EH; Chan SK; Chang WC; Chen EY; Chan TC; Swapna V; Tagata H; Tsujino N; Nemoto T; Mizuno M; Kang NI; Kim SW; Chung YC
Early Interv Psychiatry; 2019 Dec; 13(6):1329-1337. PubMed ID: 30485671
[TBL] [Abstract][Full Text] [Related]
37. Perspective on medication decisions following remission from first-episode psychosis.
Hui CLM; Lam BST; Lee EHM; Chan SKW; Chang WC; Suen YN; Chen EYH
Schizophr Res; 2020 Nov; 225():82-89. PubMed ID: 32115314
[TBL] [Abstract][Full Text] [Related]
38. Long-acting antipsychotic medication as first-line treatment of first-episode psychosis with comorbid substance use disorder.
Abdel-Baki A; Thibault D; Medrano S; Stip E; Ladouceur M; Tahir R; Potvin S
Early Interv Psychiatry; 2020 Feb; 14(1):69-79. PubMed ID: 31125513
[TBL] [Abstract][Full Text] [Related]
39. Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trial.
Moncrieff J; Crellin N; Stansfeld J; Cooper R; Marston L; Freemantle N; Lewis G; Hunter R; Johnson S; Barnes T; Morant N; Pinfold V; Smith R; Kent L; Darton K; Long M; Horowitz M; Horne R; Vickerstaff V; Jha M; Priebe S
Lancet Psychiatry; 2023 Nov; 10(11):848-859. PubMed ID: 37778356
[TBL] [Abstract][Full Text] [Related]
40. Negative symptoms predict high relapse rates and both predict less favorable functional outcome in first episode psychosis, independent of treatment strategy.
Wunderink L; van Bebber J; Sytema S; Boonstra N; Meijer RR; Wigman JTW
Schizophr Res; 2020 Feb; 216():192-199. PubMed ID: 31866076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
